EC approves Pelmeg: Mundipharma’s answer to chemotherapy-induced neutropenia

Mundipharma, a German pharmaceutical company, has achieved a significant milestone with the European Commission (EC)'s approval of Pelmeg, its pegylated biosimilar to Amgen’s Neulasta (pegfilgrastim). ... Read More